1. WHO Classification of Tumours, Female Genital Tumours. 5th ed. Lyon: International Agency for Research on Cancer, 2020. P. 32-5.
2. Blaunstein's Pathology of the Female Genital Tract, 7th ed. Switerland: Springer Nature, 2019. P. 842-966.
3. Labidi-Galy SI, Papp E, Hallberg D, Niknafs N, Adleff V, Noe M, et al. High grade serous ovarian carcinomas originate in the fallopian tube. Nat Commun. 2017; 8(1): 1093. http://doi.10.1038/s41467-017-00962-1.
4. Longacre TA, McKenney JK, Tazelaar HD, Kempson RL, Hendrickson MR. Ovarian serous tumors of low malignant potential (borderline tumors): outcome-based study of 276 patients with long-term (> or =5-year) follow-up. Am J Surg Pathol. 2005; 29(6): 707-23. htt://doi.10.1097/01.pas.0000164030.82810.db.
5. Kim KR, Lee HI, Lee SK, Ro JY, Robboy SJ. Is stromal microinvasion in primary mucinous ovarian tumors with "mucin granuloma" true invasion? Am J Surg Pathol. 2007; 31(4): 546-54. htt://doi.10.1097/01.pas.0000213430.68998.2c.
6. Sonnenberg A, de Melker AA, Martinez de Velasco AM, Janssen H, Calafat J, Niessen CM. Formation of hemidesmosomes in cells of a transformed murine mammary tumor cell line and mechanisms involved in adherence of these cells to laminin and kalinin. J Cell Sci. 1993; 106 ( Pt 4): 1083-102.
7. Goldfinger LE, Hopkinson SB, deHart GW, Collawn S, Couchman JR, Jones JC. The alpha3 laminin subunit, alpha6beta4 and alpha3beta1 integrin coordinately regulate wound healing in cultured epithelial cells and in the skin. J Cell Sci. 1999; 112 ( Pt 16): 2615-29.
8. Zhang K, Kramer RH. Laminin 5 deposition promotes keratinocyte motility. Exp Cell Res. 1996; 227(2): 309-22. htt://doi.10.1006/excr.1996.0280.
9. Ogawa T, Tsubota Y, Hashimoto J, Kariya Y, Miyazaki K. The short arm of laminin gamma2 chain of laminin-5 (laminin-332) binds syndecan-1 and regulates cellular adhesion and migration by suppressing phosphorylation of integrin beta4 chain. Mol Biol Cell. 2007; 18(5): 1621-33. htt://doi.10.1091/mbc.e06-09-0806.
10. Gasparoni A, Della Casa M, Milillo L, Lorenzini G, Rubini C, Urso R, et al. Prognostic value of differential expression of Laminin-5 gamma2 in oral squamous cell carcinomas: correlation with survival. Oncol Rep. 2007; 18(4): 793-800.
11. Giannelli G, Antonaci S. Biological and clinical relevance of Laminin-5 in cancer. Clin Exp Metastasis. 2000; 18(6): 439-43. htt://doi.10.1023/a:1011879900554.
12. Giannelli G, Falk-Marzillier J, Schiraldi O, Stetler-Stevenson WG, Quaranta V. Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5. Science. 1997; 277(5323): 225-8. htt://doi.10.1126/science.277.5323.225.
13. Mizushima H, Koshikawa N, Moriyama K, Takamura H, Nagashima Y, Hirahara F, et al. Wide distribution of laminin-5 gamma 2 chain in basement membranes of various human tissues. Horm Res. 1998; 50 Suppl 2: 7-14. htt://doi. 10.1159/000053118.
14. Burgeson RE, Chiquet M, Deutzmann R, Ekblom P, Engel J, Kleinman H, et al. A new nomenclature for the laminins. Matrix Biol. 1994; 14(3): 209-11. htt://doi.10.1016/0945-053x(94)90184-8.
15. Haas KM, Berndt A, Stiller KJ, Hyckel P, Kosmehl H. A comparative quantitative analysis of laminin-5 in the basement membrane of normal, hyperplastic, and malignant oral mucosa by confocal immunofluorescence imaging. J Histochem Cytochem. 2001; 49(10): 1261-8. htt://doi.10.1177/002215540104901008.
16. Hao J, Yang Y, McDaniel KM, Dalkin BL, Cress AE, Nagle RB. Differential expression of laminin 5 (alpha 3 beta 3 gamma 2) by human malignant and normal prostate. Am J Pathol. 1996; 149(4): 1341-9.
17. Katayama M, Sekiguchi K. Laminin-5 in epithelial tumour invasion. J Mol Histol. 2004; 35(3): 277-86. htt://doi. 10.1023/b:hijo.0000032359.35698.fe.
18. Koshikawa N, Moriyama K, Takamura H, Mizushima H, Nagashima Y, Yanoma S, et al. Overexpression of laminin gamma2 chain monomer in invading gastric carcinoma cells. Cancer Res. 1999; 59(21): 5596-601.
19. Maatta M, Soini Y, Paakko P, Salo S, Tryggvason K, Autio-Harmainen H. Expression of the laminin gamma2 chain in different histological types of lung carcinoma. A study by immunohistochemistry and in situ hybridization. J Pathol. 1999; 188(4): 361-8. htt://doi. 10.1002/(SICI)1096-9896(199908)188:4<361::AID-PATH363>3.0.CO;2-0
20. Miyazaki K. Laminin-5 (laminin-332): Unique biological activity and role in tumor growth and invasion. Cancer Sci. 2006; 97(2): 91-8. htt://doi. 10.1111/j.1349-7006.2006.00150.x.
21. Pyke C, Salo S, Ralfkiaer E, Romer J, Dano K, Tryggvason K. Laminin-5 is a marker of invading cancer cells in some human carcinomas and is coexpressed with the receptor for urokinase plasminogen activator in budding cancer cells in colon adenocarcinomas. Cancer Res. 1995; 55(18): 4132-9.
22. Sordat I, Bosman FT, Dorta G, Rousselle P, Aberdam D, Blum AL, et al. Differential expression of laminin-5 subunits and integrin receptors in human colorectal neoplasia. J Pathol. 1998; 185(1): 44-52. htt://doi.10.1002/(SICI)1096-9896(199805)185:1<44::AID-PATH46>3.0.CO;2-A.
23. Sentani K, Matsuda M, Oue N, Uraoka N, Naito Y, Sakamoto N, et al. Clinicopathological significance of MMP-7, laminin gamma2 and EGFR expression at the invasive front of gastric carcinoma. Gastric Cancer. 2014; 17(3): 412-22. htt ://doi.10.1007/s10120-013-0302-6.
24. Imura J, Uchida Y, Nomoto K, Ichikawa K, Tomita S, Iijima T, et al. Laminin-5 is a biomarker of invasiveness in cervical adenocarcinoma. Diagn Pathol. 2012; 7: 105. htt://doi.10.1186/1746-1596-7-105.
25. Tohmatsu Y, Imura J, Sakai T, Takagi K, Minamisaka T, Tanaka S, et al. Expression of laminin-5 gamma 2 chain predicts invasion of extramammary Paget's disease cell. APMIS. 2021; 129(1): 3-8. htt://doi. 10.1111/apm.13086.